Riskpilot← Back to searchSign inGet full accessArs Chirurgica Konsult AB
ABActiveOrg 5568748460Blekerigatan 1Medical specialists activities · NACE 8622Est. 20110 employees
Revenue 2025
SEK 99K
-87% vs 2024
EBITDA margin
-45.5%
+92% vs 2024
Equity ratio
96.9%
Financial strength
Net profit 2025
SEK -99K
+85% vs 2024
| Revenue | SEK 99K | -87% |
| EBITDA | SEK -45K | +92% |
| Net profit | SEK -99K | +85% |
| Total assets | SEK 881K | -16% |
| Equity | SEK 854K | -10% |
| Employees | 0 | — |
Legal name
Ars Chirurgica Konsult AB
Org number
5568748460
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva specialistmottagning med läkare.
Address
Blekerigatan 1
Email
info@dalslandskliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 591 | 2 958 | 2 438 | 734 | 99 |
| Staff expenses | — | — | — | −804 | — |
| EBITDA | 3 575 | 381 | −153 | −572 | −45 |
| Depreciation & amort. | −77 | −80 | −86 | −86 | −54 |
| EBIT | 3 498 | 301 | −239 | −659 | −99 |
| Net financials | −18 | −14 | −22 | −8 | 1 |
| Profit before tax | 2 617 | 736 | 165 | −679 | −99 |
| Tax | −554 | −166 | −57 | — | −0 |
| Net profit | 2 063 | 570 | 108 | −679 | −99 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 174 | 3 425 | 1 999 | 1 055 | 881 |
| Equity | 2 210 | 2 098 | 1 632 | 953 | 854 |
| Long-term debt | 316 | 156 | 60 | 0 | 0 |
| Short-term debt | 785 | 758 | 319 | 101 | 27 |
| Total debt | 1 101 | 914 | 379 | 101 | 27 |
EBITDA margin
-45.5%
This company
15.8%
Market median
-388% vs market
20212025
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
-11.6%
This company
18.4%
Market median
-163% vs market
20212025
Net profit margin
-100.0%
This company
8.1%
Market median
-1335% vs market
20212025
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ars Clinica Konsult AB
Ars Chirurgica Konsult AB Board members of Ars Chirurgica Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Angelo Termini | Board of Directors | 0 companies |
| Maj-Britt Irene Mattsson | Deputy Board Member | 0 companies |
| Christina Ulrica Marie Mattsson | Board of Directors | 0 companies |
| Ulf Gregor Ryder | Deputy Board Member | 0 companies |